A chance for a new beginning in days
First and only
ZULRESSO is the first and only FDA-approved medicine specifically for postpartum depression (PPD).
In clinical studies, moms treated with ZULRESSO experienced a greater reduction in symptoms of PPD vs placebo in 2.5 days. Symptoms were measured at the beginning of treatment using a standard depression scale and again at the end of treatment.*
In these studies, moms who took ZULRESSO generally still felt better 30 days after treatment began, as measured by a standard depression scale. This 30-day measurement was also a preplanned part of the study.*
*Individual results may vary.
The most common side effects of ZULRESSO include: